Streetbeat News

Regulatory

FROG

JFrog has been added to the Department of Defense Enterprise Software Initiative's DevSecOps Agency Catalog, allowing defense organizations to integrate JFrog's software supply chain platform into U.S. government IT modernization efforts.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 1:15 pm

ABBV

EWC

AbbVie has announced that its drug EPKINLY has been listed on Ontario Health (Cancer Care Ontario) Formulary and Quebec's RAMQ for the treatment of relapsed or refractory diffuse large B-cell lymphoma in adult patients after two or more lines of therapy.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 1:15 pm

GILD

The FDA has granted accelerated approval for Gilead Sciences' (NASDAQ:GILD) drug Livdelzi (seladelpar) for treating primary biliary cholangitis (PBC). This approval follows Gilead's $4.3 billion acquisition of CymaBay Therapeutics. The approval is based on Phase 3 study data showing significant improvements in patients. However, continued approval is contingent on further clinical trials. Gilead's stock was down 0.04% in premarket trading.

Portfolio Pulse from Vandana Singh

August 15, 2024 | 1:09 pm

MGM

MGM Resorts International and Grupo Globo have formed a new venture to seek a sports betting and iGaming license in Brazil. If approved, the venture will launch in early 2025 under the BetMGM brand.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 1:06 pm

SIGA

The National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) announced that SIGA Technologies' antiviral tecovirimat did not meet its primary endpoint in a study for treating monkeypox virus in the Democratic Republic of the Congo. The study showed no statistically significant improvement in lesion resolution within 28 days. SIGA's stock dropped 38.3% following the news.

Portfolio Pulse from Vandana Singh

August 15, 2024 | 1:01 pm

QNTM

Trading halt status was updated at 8:55:00 AM ET, indicating a resumption of quotations. The news and resumption times are provided.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 12:55 pm

GDHG

Golden Heaven Group shares are trading lower after the company received a Nasdaq Delisting notice.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 12:41 pm

CING

Cingulate shares are trading higher after the company was granted European patent No. 3261625 for CTx-1301, its lead asset for the treatment of ADHD.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 12:32 pm

GOOG

GOOGL

Alphabet Inc. (NASDAQ:GOOGL) (NASDAQ:GOOG) is appealing against the DOJ's antitrust ruling to avoid a potential breakup. Analyst Ray Wang discussed the market's anticipation of the appeal and the implications of Alphabet's exclusive deals with companies like Apple. Despite the DOJ's victory, a breakup is considered unlikely by some experts.

Portfolio Pulse from Benzinga Neuro

August 15, 2024 | 12:26 pm

SIGA

SIGA Technologies shares are trading lower after the National Institutes of Health's National Institute of Allergy and Infectious Diseases announced that the PALM 007 trial of Tecovirimat for Monkeypox virus did not meet its primary endpoint.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 12:14 pm